METHOD FOR SCREENING IMMUNE CHECKPOINT INHIBITOR
Provided herein is a method for screening an immune checkpoint inhibitor, the method comprising the steps of: primarily culturing a biological specimen isolated from a subject to enrich T cells; treating the enriched T cells with immune checkpoint inhibitors; secondarily culturing a mixture of the i...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French Korean |
Published |
07.07.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided herein is a method for screening an immune checkpoint inhibitor, the method comprising the steps of: primarily culturing a biological specimen isolated from a subject to enrich T cells; treating the enriched T cells with immune checkpoint inhibitors; secondarily culturing a mixture of the immune checkpoint inhibitor-treated T cells and a cancer cell strain in which a gene for an immune checkpoint ligand is knocked out; and measuring a level of cytokines secreted from the secondarily cultured T cells.
La présente invention concerne une méthode de criblage d'un inhibiteur de point de contrôle immunitaire, la méthode consistant : à mettre en culture premièrement un échantillon biologique isolé d'un sujet afin d'enrichir des lymphocytes T ; à traiter les lymphocytes T enrichis avec des inhibiteurs de point de contrôle immunitaire ; à mettre en culture deuxièmement un mélange des lymphocytes T traités par inhibiteurs de point de contrôle immunitaire avec une souche de cellules cancéreuses dans laquelle un gène destiné à un ligand de point de contrôle immunitaire est inactivé ; et à mesurer un niveau de cytokines secrétées par les lymphocytes T de la deuxième culture.
본 명세서에서는 개체로부터 분리된 생물학적 시료를 T세포가 농축(enrichment)되도록 제 1 배양하는 단계, 농축된 상기 T세포에 면역 관문 저해제(immune checkpoint inhibitors)를 처리하는 단계, 면역 관문 저해제가 처리된 상기 T세포와 면역관문 리간드(immune checkpoint ligand)에 대한 유전자가 녹아웃(knock-out)된 암 세포주를 혼합하여 제 2 배양하는 단계, 및 제 2 배양된 상기 T세포의 싸이토카인 분비량을 측정하는 단계를 포함하는, 면역 관문 저해제의 스크리닝 방법을 제공한다. |
---|---|
Bibliography: | Application Number: WO2021KR19728 |